Cargando…
Tying Small Changes to Large Outcomes: The Cautious Promise in Incorporating the Microbiome into Immunotherapy
The role of the microbiome in immunology is a rapidly burgeoning topic of study. Given the increasing use of immune checkpoint inhibitor (ICI) therapy in cancers, along with the recognition that carcinogenesis has been linked to dysregulations of the immune system, much attention is now directed at...
Autores principales: | Chau, Justin, Zhang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347117/ https://www.ncbi.nlm.nih.gov/pubmed/34360663 http://dx.doi.org/10.3390/ijms22157900 |
Ejemplares similares
-
Cautious apoptosis
por: Wells, William A.
Publicado: (2003) -
Exploring Gut Microbiome in Predicting the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer
por: Liu, Ben, et al.
Publicado: (2022) -
Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer
por: Temraz, Sally, et al.
Publicado: (2019) -
Promise, perils and cautious optimism: the next frontier in long-acting modalities for the treatment and prevention of HIV
por: Philbin, Morgan M., et al.
Publicado: (2022) -
Blue cures blue but be cautious
por: Sikka, Pranav, et al.
Publicado: (2011)